Alnylam Pharmaceuticals, Inc.

UNITED CAPITAL FINANCIAL ADVISORS, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

2,449

Value ($000)

974

Weight

0.0%

2013 Q4 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	974	0.0%	2,449	12/31/2025
2025 Q3	11/14/2025	978	0.0%	2,145	9/30/2025
2025 Q2	8/11/2025	514	0.0%	1,575	6/30/2025
2025 Q1	5/13/2025	414	0.0%	1,532	3/31/2025
2024 Q4	2/13/2025	348	0.0%	1,480	12/31/2024
2024 Q3	11/12/2024	431	0.0%	1,568	9/30/2024
2024 Q2	8/14/2024	369	0.0%	1,520	6/30/2024
2021 Q2	8/13/2021	235	0.0%	1,387	6/30/2021
2021 Q1	5/14/2021	210	0.0%	1,487	3/31/2021
2020 Q4	2/17/2021	410	0.0%	3,156	12/31/2020
2020 Q3	11/13/2020	5,200	0.0%	35,716	9/30/2020
2020 Q2	8/13/2020	4,921	0.0%	33,225	6/30/2020
2014 Q1	5/14/2014	235	0.0%	3,500	3/31/2014
2013 Q4	2/20/2014	225	0.0%	3,500	12/31/2013